Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Covaris Strike Co-Marketing Pact for Sequencing Techs

NEW YORK (GenomeWeb News) – Agilent Technologies and Covaris have struck a co-marketing agreement for their target enrichment and DNA shearing technologies for next-generation sequencing studies, Agilent said today.

Under the agreement, the Covaris S2 DNA shearing technology will be marketed with Agilent's SureSelect Target Enrichment System to researchers using next-generation sequencing.

The Covaris technology uses the firm's Adaptive Focused Acoustic method for biological and chemical sample preparation, and it provides a "predictable and reproducible" DNA shearing method that can limit the amount of DNA lost in the process, the company said.

As part of the agreement, Covaris has developed a SureSelect Accessory Kit to help integrate the Agilent and Covaris workflows, Agilent said.

The companies will continue to work together to develop new protocols and products for the SureSelect and Covaris S2 systems, the partners added.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.